688799.SH
华纳药厂
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 43.33
−0.73%Margins
Gross margin
59.0%
EBITDA margin
21.3%
EBIT margin
15.2%
Net margin
15.0%
FCF margin
-18.6%
10.8%
Return on equity
6.9%
Return on assets
8.3%
Return on invested capital
0.47x
Asset turnover
CNY 331.7M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026